Suchergebnisse - "Gentilini, Lucas"

PubPharm (20)

1

Galectin-3 as a new negative checkpoint of the immune response is the key target for effective immunotherapy against prostate cancer

enthalten in: bioRxiv.org | 2023

von Tiraboschi, C. | Gentilini, L. | Jaworski, F. | +5

2

Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease : Preclinical Evaluation

enthalten in: Drugs in R&D | 2023

von van Kuilenburg, A. | Hollak, C. | Travella, A. | +9

3

Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation

enthalten in: Drugs in R & D | 2023

von van Kuilenburg, A. | Hollak, C. | Travella, A. | +9

4

Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation

enthalten in: Drugs in R & D | 2023

von van Kuilenburg, A. | Hollak, C. | Travella, A. | +9

5

Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation

enthalten in: Drugs in R & D | 2023

von van Kuilenburg, A. | Hollak, C. | Travella, A. | +9

6

Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome

enthalten in: Journal for immunotherapy of cancer | 2020

von Tiraboschi, C. | Gentilini, L. | Velazquez, C. | +7

7

Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases : results from the PelvEx Collaborative

enthalten in: Colorectal disease | 2020

von Kelly, M. | Aalbers, A. | Abdul Aziz, N. | +223

8

Predicting outcomes of pelvic exenteration using machine learning

enthalten in: Colorectal disease | 2020

von Dudurych, I. | Kelly, M. | Aalbers, A. | +230

9

In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Jaworski, F. | Gentilini, L. | Gueron, G. | +9

10

Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer

enthalten in: Oncotarget | 2017

von Gentilini, L. | Jaworski, F. | Tiraboschi, C. | +5